The materials for DUPIXENT contained in this virtual exhibition are approved for use only in the United States of America. Prescribing information may vary depending on local approval in each country. Therefore, before prescribing any product, always refer to local materials such as the full Prescribing Information and/or the Summary of Product Characteristics (SPC).

SKIP

WELCOME TO A VIRTUAL
CONVENTION EXPERIENCE

PATIENT CONVERSATION GUIDE

Use this guide during discussions
with your appropriate patients

VIEW MOA

Explore the science behind the mechanism of action of DUPIXENT

HEAR FROM THE EXPERTS

Dr Tan: Discussing the MOA of DUPIXENT


Dr Tan: Discussing a Patient Case for DUPIXENT

PATIENT EFFICACY & SAFETY

View the data for DUPIXENT

DUPIXENT MyWay®

Enrollment Video: Information to help your appropriate patients with the enrollment process


Delivery Video: See how your appropriate patients can access DUPIXENT

NOW APPROVED: DUPIXENT 300 MG PRE-FILLED PEN

Explore this new administration option

AVAILABLE LATE AUGUST 2020

APPROVED FOR 3 INDICATIONS


EXPLORE ADDITIONAL
INDICATIONS
SWIPE TO EXPLORE

EOS, eosinophils; OCS, oral corticosteroid.